The Effect of Anti-Neoplastic Drugs on Murine Acquired Immunodeficiency Syndrome
- 18 January 1991
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 251 (4991) , 305-308
- https://doi.org/10.1126/science.1987646
Abstract
The murine acquired immunodeficiency syndrome (MAIDS) is associated with proliferation of target cells that have been infected by a defective retrovirus. To control the growth of this primary neoplasia, virus-inoculated mice were treated with anti-neoplastic drugs. Paradoxically, cyclophosphamide, which is also immunosuppressive, was very effective in preventing the appearance and progression of the disease, in restoring a normal T cell function, and in depleting the number of infected target cells. This result suggests that the proliferating infected target cells were responsible for the immunodeficiency.Keywords
This publication has 13 references indexed in Scilit:
- Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14Nature, 1990
- Immunodeficiency and Clonal Growth of Target Cells Induced by Helper-Free Defective RetrovirusScience, 1989
- Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome.Proceedings of the National Academy of Sciences, 1989
- Severe immunodeficiency disease induced by a defective murine leukaemia virusNature, 1989
- The Human Immunodeficiency Virus: Infectivity and Mechanisms of PathogenesisScience, 1988
- Animal Models for Retrovirus-Induced Immunodeficiency DiseaseImmunological Investigations, 1986
- Molecular, cellular and animal pharmacology of 5-AZA-2′-deoxycytidinePharmacology & Therapeutics, 1985
- Human T-lymphotropic retrovirusesNature, 1985
- Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice.The Journal of Experimental Medicine, 1985
- Characteristics of the cell populations involved in extra-thymic lymphosarcoma induced in C57BL/6 mice by RadLV-RsLeukemia Research, 1981